Improved bioavailability and site specific delivery of poorly water soluble drugs through the production of stabilized drug nanoparticles
Bioavailability enhancement of poorly water soluble active pharmaceutical ingredients (API) is key for improving existing therapies and allowing for formulation of certain new chemical entities. The rate limiting step for absorption of these APIs is dependent on the dissolution rate and the APIs app...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | English |
| Published: |
2011
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/2152/9770 |